Search results
Results from the WOW.Com Content Network
Many within the industry had been anxiously awaiting the FDA’s updated proposed requirements for sunscreens, which were to be issued in late 2019 via a new over-the-counter (OTC) sunscreen ...
The FDA's ability to approve the chemical filters in sunscreens that are sold in other countries is hamstrung by a 1938 U.S. law that sunscreen makers say is unfair. A decades-old FDA rule is ...
Coppertone is recalling five of its sunscreen products due to the presence of benzene, a chemical that can cause cancer with repeated exposure. Sunscreen recall 2021: Coppertone recalling select ...
As an over-the-counter drug, sunscreen ingredients must be approved by the FDA. In Europe, where sunscreens are considered a cosmetic product, they are subject to a faster review process. As a result, European consumers have access to a wide range of more advanced sunscreen products not available in the U.S. [citation needed] Most European ...
Avobenzone was patented in 1973 and was approved in the EU in 1978. It was approved by the FDA in 1988. As of 2021, the FDA announced that they do not support avobenzone as being generally recognized as safe and effective (GRASE) [1] citing the need for additional safety data. Avobenzone was banned in 2020 by the Palau government citing reef ...
* Time and Extent Application (TEA), Proposed Rule on FDA approval originally expected 2009, now expected 2015. [needs update] Many of the ingredients awaiting approval by the FDA are relatively new, and developed to absorb UVA. [107] The 2014 Sunscreen Innovation Act was passed to accelerate the FDA approval process. [108] [109]
The U.S. Food and Drug Administration (FDA) is investigating how a cancer-causing chemical ended up in Johnson & Johnson sunscreens, after the company said it had done internal testing and found ...
The company behind Banana Boat is recalling more of its sunscreen products due to the presence of a cancer-causing chemical. Banana Boat expands sunscreen recall due to cancer risk Skip to main ...